Insiders

09/06 Gsk plc Announces Board and Committee Changes CI
30/04 GSK plc: A beat isn't enough; markets expected an outlook upgrade Alphavalue
09/03 GSK plc Appoints Elizabeth McKee Anderson as Member of the Corporate Responsibility Committee, Effective March 9, 2026 CI
20/02 GSK non-executive director buys nearly GBP75,000 in shares AN
17/02 Berenberg Says GSK 'Best Performer' in Pharmaceutical Sector; Price Target Up MT
06/02 GSK Chair Jonathan Symonds buys GBP53,000 in shares AN
04/02 GSK optimistic for 2026 after fourth-quarter results beat forecast AN
04/02 GSK's Specialty Medicines Drive Solid Results DJ
04/02 GSK forecasts slower sales growth in 2026 RE
04/02 GSK eyes sharper, faster drug development as new CEO signals growth plan RE
02/02 GSK cutting jobs in UK and US as part of ongoing R&D changes AN
08/01 GSK plc Appoints Luke Victor Miels as Director, Effective January 1, 2026 CI
05/01 GSK PLC Announces Termination of Director Appointment of Emma Natasha Walmsley, Effective December 31, 2025 CI
30/12 GSK PLC outlook improves amid merger speculation Alphavalue
29/25/29 GSK lifts sales and profit outlook as Specialty Medicines unit shines AN
29/25/29 GSK Taps Miels as CEO With Walmsley Stepping Down MT
29/25/29 GSK Names Chief Commercial Officer as CEO Designate MT
29/25/29 GSK plc Announces Board Changes CI
29/25/29 Gsk plc Announces CEO Changes CI
29/25/29 GSK Names Luke Miels CEO Designate MT
29/25/29 Luke Miels appointed CEO of GSK from January 1, 2026 Zonebourse
29/25/29 Who is GSK's next CEO Luke Miels? RE
29/25/29 GSK commercial chief to become CEO at start of "pivotal" 2026 AN
29/25/29 GSK Names Luke Miels to Succeed CEO Emma Walmsley -- Update DJ
29/25/29 GSK Names Luke Miels to Succeed CEO Emma Walmsley DJ
No results match your criteria
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!